Sickle cell disease (NORD)


00:00 / 00:00



Sickle cell disease (NORD)



Iron deficiency anemia



Sideroblastic anemia

Anemia of chronic disease

Lead poisoning

Hemolytic disease of the newborn

Glucose-6-phosphate dehydrogenase (G6PD) deficiency

Autoimmune hemolytic anemia

Pyruvate kinase deficiency

Paroxysmal nocturnal hemoglobinuria

Sickle cell disease (NORD)

Hereditary spherocytosis

Anemia of chronic disease

Aplastic anemia

Fanconi anemia

Megaloblastic anemia

Folate (Vitamin B9) deficiency

Vitamin B12 deficiency

Fanconi anemia

Diamond-Blackfan anemia

Heme synthesis disorders

Acute intermittent porphyria

Porphyria cutanea tarda

Lead poisoning

Coagulation disorders


Vitamin K deficiency

Platelet disorders

Bernard-Soulier syndrome

Glanzmann's thrombasthenia

Hemolytic-uremic syndrome

Immune thrombocytopenic purpura

Thrombotic thrombocytopenic purpura

Mixed platelet and coagulation disorders

Von Willebrand disease

Disseminated intravascular coagulation

Heparin-induced thrombocytopenia

Thrombosis syndromes (hypercoagulability)

Antithrombin III deficiency

Factor V Leiden

Protein C deficiency

Protein S deficiency

Antiphospholipid syndrome


Hodgkin lymphoma

Non-Hodgkin lymphoma


Chronic leukemia

Acute leukemia

Leukemoid reaction

Leukemoid reaction

Dysplastic and proliferative disorders

Myelodysplastic syndromes

Polycythemia vera (NORD)

Myelofibrosis (NORD)

Essential thrombocythemia (NORD)

Langerhans cell histiocytosis

Mastocytosis (NORD)

Plasma cell dyscrasias

Multiple myeloma

Monoclonal gammopathy of undetermined significance

Waldenstrom macroglobulinemia

Hematological system pathology review

Microcytic anemia: Pathology review

Non-hemolytic normocytic anemia: Pathology review

Intrinsic hemolytic normocytic anemia: Pathology review

Extrinsic hemolytic normocytic anemia: Pathology review

Macrocytic anemia: Pathology review

Heme synthesis disorders: Pathology review

Coagulation disorders: Pathology review

Platelet disorders: Pathology review

Mixed platelet and coagulation disorders: Pathology review

Thrombosis syndromes (hypercoagulability): Pathology review

Lymphomas: Pathology review

Leukemias: Pathology review

Plasma cell disorders: Pathology review

Myeloproliferative disorders: Pathology review


Sickle cell disease (NORD)


0 / 17 complete

USMLE® Step 1 questions

0 / 3 complete

High Yield Notes

13 pages


Sickle cell disease (NORD)

of complete


USMLE® Step 1 style questions USMLE

of complete

A 35-year-old man comes to the primary care office complaining of mild fatigue and shortness of breath. The patient has a past medical history significant for episodes of jaundice and intermittent right upper quadrant abdominal pain, which he has never been to the doctor for before. Temperature is 37.2°C (98.9°F), pulse is 72/min, respirations are 18/min, and blood pressure is 128/88 mmHg. Physical examination shows splenomegaly. Laboratory tests are obtained, and the results are shown below.  

Peripheral blood smear shows hexagonal crystals and target cells. This patient’s disease is most likely caused by a substitution of glutamic acid with which of the following amino acids?

External References

First Aid








Aplastic crisis

sickle cell anemia p. 417


sickle cell anemia p. 417

Avascular necrosis p. 473

sickle cell anemia p. 417


sickle cell anemia p. 417


in sickle cell anemia p. 423

Hydroxyurea p. 448

sickle cell anemia p. 417


sickle cell anemia in p. 417

Osteomyelitis p. 177

sickle cell anemia p. 417

Priapism p. 675

sickle cell anemia p. 417

Renal papillary necrosis p. 625

sickle cell anemia p. 417

Sickle cell anemia p. 417

in anemia taxonomy p. 425

ESR in p. 212

sickle cells in p. 423

Sickle cell disease

autosplenectomy p. 730

missense mutation p. 38

osteonecrosis and p. 473

postsplenectomy state in p. 96

priapism p. 675

renal papillary necrosis p. 627

Stroke p. 529

sickle cell anemia p. 417


sickle cell disease p. 38


Content Reviewers

Rishi Desai, MD, MPH


Tanner Marshall, MS

Sickle cell disease, also called sickle cell anemia or just “sickle cell,” is a genetic disease where red blood cells can take the shape of a crescent, or sickle, and that change allows them to more easily be destroyed, causing anemia among other things.

Sickle cell disease is caused by defective hemoglobin, which is the oxygen-carrying protein in red blood cells. Hemoglobin is actually made up of four peptide chains, each bound to a heme group.

Different hemoglobins have different combinations of these chains. Hemoglobin A (or HbA), made up of two α-globin and two β-globin peptide chains, is the primary hemoglobin affected in sickle cell.

Specifically, the β-globin chains end up misshapen. This is because of a mutation in the beta globin gene, or HBB gene.

Sickle cell is an autosomal recessive disease, so a mutation in both copies of the beta globin gene is needed to get the disease; if the person has just one copy of the mutation and one normal HBB gene, then they’re a sickle cell carrier, also called sickle trait.

Having sickle trait doesn’t cause health problems unless the person is exposed to extreme conditions like high altitude or dehydration, where some sickle cell disease-like symptoms can crop up.

What it does do is decrease the severity of infection by Plasmodium falciparum malaria, so in parts of the world with a high malaria burden, like Africa and pockets of southern Asia, those with sickle trait actually have an evolutionary advantage.

This phenomenon is called heterozygote advantage, and it's unfortunate consequence is a high rate of sickle cell disease in people from these parts of the world.

Almost always, the sickle cell mutation is a nonconservative missense mutation that results in the 6th amino acid of beta globin being a valine instead of glutamic acid.


Sickle cell disease is an autosomal recessive genetic disorder, in which the beta-globin subunit of hemoglobin is misshapen, causing red blood cells to sickle when deoxygenated, which leads to their premature destruction as well as vaso-occlusion. Sickle-cell disease is associated with several acute and chronic health problems, such as severe infections, attacks of severe pain ("sickle-cell crisis"), stroke, and an increased risk of death.

Symptoms of sickle cell disease can vary and may include episodes of severe pain, fatigue, shortness of breath, anemia, and frequent infections. The severity and frequency of symptoms can vary widely among individuals with the condition, and some people may experience only mild symptoms, while others may have more severe and frequent episodes of pain and organ damage.

Treatment for sickle cell disease may involve pain management, blood transfusions, and antibiotics to prevent infections. In some cases, a bone marrow transplant may be necessary to cure the condition. Additionally, individuals with sickle cell disease may need to make lifestyle changes, such as avoiding extreme temperatures, staying hydrated, and managing stress, to help prevent and manage symptoms.


Copyright © 2023 Elsevier, except certain content provided by third parties

Cookies are used by this site.

USMLE® is a joint program of the Federation of State Medical Boards (FSMB) and the National Board of Medical Examiners (NBME). COMLEX-USA® is a registered trademark of The National Board of Osteopathic Medical Examiners, Inc. NCLEX-RN® is a registered trademark of the National Council of State Boards of Nursing, Inc. Test names and other trademarks are the property of the respective trademark holders. None of the trademark holders are endorsed by nor affiliated with Osmosis or this website.